A Nevada jury is ordering pharmaceutical companies to pay $162.5 million in punitive damages in a lawsuit stemming from a Las Vegas hepatitis C outbreak in 2008.
The damages awarded Monday in Clark County District Court are on top of the $20.1 million in compensatory damages awarded to five plaintiffs Thursday after a jury found Teva Parenteral Medicines Inc., Baxter Healthcare Corp. and McKesson Corp. liable after a seven-week trial.
Plaintiffs’ lawyers had been seeking $600 million in punitive damages.
At least one of the drug companies is planning an immediate appeal.
Plaintiffs accused the drug companies of distributing dangerously large vials of the powerful anesthetic propofol to clinics where doctors and anesthesiologists are suspected of reusing vials – despite warnings that the practice could spread blood-borne diseases.
Was this article valuable?
Here are more articles you may enjoy.
Credit Suisse Nazi Probe Reveals Fresh SS Ties, Senator Says
These Five Technologies Increase The Risk of Cyber Claims
Portugal Rolls Out $2.9 Billion Aid as Deadly Flooding Spreads
One out of 10 Cars Sold in Europe Is Now Made by a Chinese Brand